065660 Stock Chart & Stats
₩14950.00
-₩840.00(-5.32%)
―
--
Day’s Range― - ―
52-Week Range₩13,500.00 - ₩61,800.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)44.73K
Market Cap
₩158.00B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.09
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding10,006,100
10 Day Avg. Volume89,635
30 Day Avg. Volume44,733
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
065660 FAQ
What was Anterogen Co., Ltd.’s price range in the past 12 months?
Anterogen Co., Ltd. lowest stock price was ₩13500.00 and its highest was ₩61800.00 in the past 12 months.
What is Anterogen Co., Ltd.’s market cap?
Anterogen Co., Ltd.’s market cap is ₩158.00B.
When is Anterogen Co., Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Anterogen Co., Ltd.’s earnings last quarter?
Anterogen Co., Ltd. released its earnings results on May 15, 2026. The company reported -₩88.173 earnings per share for the quarter, missing the consensus estimate of N/A by -₩88.173.
Is Anterogen Co., Ltd. overvalued?
According to Wall Street analysts Anterogen Co., Ltd.’s price is currently Undervalued.
Does Anterogen Co., Ltd. pay dividends?
Anterogen Co., Ltd. does not currently pay dividends.
What is Anterogen Co., Ltd.’s EPS estimate?
Anterogen Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Anterogen Co., Ltd. have?
Anterogen Co., Ltd. has 10,006,100 shares outstanding.
What happened to Anterogen Co., Ltd.’s price movement after its last earnings report?
Anterogen Co., Ltd. reported an EPS of -₩88.173 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.695%.
Which hedge fund is a major shareholder of Anterogen Co., Ltd.?
Currently, no hedge funds are holding shares in KR:065660
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
GC CELL CORPORATION
―
DuChemBIO Co., Ltd.
―
NKGen Biotech Korea Co., Ltd.
―
Cellbion Co., Ltd
―
Curacle Co., Ltd.
―